title: Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction.
abstract: Tumor heterogeneity is a limiting factor in cancer treatment and in the discovery of biomarkers to personalize it. We describe a computational purification tool, ISOpure, to directly address the effects of variable normal tissue contamination in clinical tumor specimens. ISOpure uses a set of tumor expression profiles and a panel of healthy tissue expression profiles to generate a purified cancer profile for each tumor sample and an estimate of the proportion of RNA originating from cancerous cells. Applying ISOpure before identifying gene signatures leads to significant improvements in the prediction of prognosis and other clinical variables in lung and prostate cancer.
authors.forename: Gerald
authors.initials: G
authors.lastname: Quon
authors.forename: Syed
authors.initials: S
authors.lastname: Haider
authors.forename: Amit G
authors.initials: AG
authors.lastname: Deshwar
authors.forename: Ang
authors.initials: A
authors.lastname: Cui
authors.forename: Paul C
authors.initials: PC
authors.lastname: Boutros
authors.forename: Quaid
authors.initials: Q
authors.lastname: Morris
references.citation: BMC Genomics. 2006 Oct 30;7:278
references.pmid: 17074082
references.citation: Cancer Res. 2008 Feb 1;68(3):927-36
references.pmid: 18245496
references.citation: Nature. 2002 Jan 31;415(6871):530-6
references.pmid: 11823860
references.citation: Nat Med. 2010 Jul;16(7):781-7
references.pmid: 20581836
references.citation: PLoS One. 2011 Jan 27;6(1):e16493
references.pmid: 21304595
references.citation: Clin Cancer Res. 2006 Oct 1;12(19):5632-40
references.pmid: 17020965
references.citation: J Clin Oncol. 2005 Oct 1;23(28):7005-12
references.pmid: 16192588
references.citation: Nat Med. 2002 Aug;8(8):816-24
references.pmid: 12118244
references.citation: Br J Cancer. 2010 May 11;102(10):1519-23
references.pmid: 20407439
references.citation: Nat Methods. 2008 Jul;5(7):621-8
references.pmid: 18516045
references.citation: Bioinformatics. 2007 Dec 15;23(24):3328-34
references.pmid: 17956877
references.citation: Bioinformatics. 2010 Jun 15;26(12):i106-14
references.pmid: 20529894
references.citation: Nat Rev Cancer. 2007 Apr;7(4):256-69
references.pmid: 17384581
references.citation: Lancet Oncol. 2007 Dec;8(12):1079-1087
references.pmid: 18042430
references.citation: Nat Genet. 2008 Dec;40(12):1413-5
references.pmid: 18978789
references.citation: J Urol. 2009 Mar;181(3):956-62
references.pmid: 19167731
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13790-5
references.pmid: 11707567
references.citation: J Stat Softw. 2010;33(1):1-22
references.pmid: 20808728
references.citation: Lancet Oncol. 2009 Jul;10(7):663-71
references.pmid: 19515614
references.citation: Nat Biotechnol. 2010 May;28(5):511-5
references.pmid: 20436464
references.citation: Nat Med. 2008 Aug;14(8):822-7
references.pmid: 18641660
references.citation: Bioinformatics. 2010 Oct 15;26(20):2571-7
references.pmid: 20631160
references.citation: Nature. 2011 Jun 29;474(7353):609-15
references.pmid: 21720365
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):615-20
references.pmid: 14722351
references.citation: Cancer Res. 2003 Nov 1;63(21):7167-75
references.pmid: 14612510
references.citation: BMC Bioinformatics. 2005 Mar 14;6:54
references.pmid: 15766384
references.citation: Nucleic Acids Res. 2005 Nov 10;33(20):e175
references.pmid: 16284200
references.citation: Nucleic Acids Res. 2003 Feb 15;31(4):e15
references.pmid: 12582260
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2824-8
references.pmid: 19196983
references.citation: Nat Methods. 2010 Apr;7(4):287-9
references.pmid: 20208531
references.citation: Nat Rev Genet. 2000 Oct;1(1):48-56
references.pmid: 11262874
references.citation: Cancer Res. 2003 Aug 15;63(16):5159-64
references.pmid: 12941848
references.citation: J Clin Oncol. 2007 Aug 1;25(22):3230-7
references.pmid: 17664471
references.citation: J Clin Oncol. 2009 May 20;27(15):2503-8
references.pmid: 19332734
references.citation: Am J Pathol. 2008 Aug;173(2):301-10
references.pmid: 18583314
references.citation: J Clin Oncol. 2007 Dec 10;25(35):5562-9
references.pmid: 18065728
references.citation: J Natl Cancer Inst. 2010 Apr 7;102(7):464-74
references.pmid: 20233996
references.citation: Bioinformatics. 2010 Apr 15;26(8):1043-9
references.pmid: 20202973
references.citation: Science. 1999 Oct 15;286(5439):531-7
references.pmid: 10521349
references.citation: N Engl J Med. 2008 Sep 25;359(13):1367-80
references.pmid: 18815398
references.citation: Bioinformatics. 2001;17 Suppl 1:S279-87
references.pmid: 11473019
references.citation: Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):955-60
references.pmid: 18195366
references.citation: J Clin Oncol. 2009 Nov 1;27(31):5240-7
references.pmid: 19770384
references.citation: Cancer Res. 2010 Aug 15;70(16):6448-55
references.pmid: 20663908
references.citation: Nat Rev Drug Discov. 2010 Jun;9(6):423
references.pmid: 20514061
references.citation: PLoS One. 2008 Feb 20;3(2):e1651
references.pmid: 18297132
references.citation: Bioinformatics. 2007 Apr 15;23(8):957-65
references.pmid: 17277331
references.citation: J Clin Oncol. 2010 Oct 10;28(29):4417-24
references.pmid: 20823422
references.citation: Bioinformatics. 2009 Nov 1;25(21):2882-9
references.pmid: 19542156
references.citation: Bioinformatics. 2004 Jul 22;20(11):1663-9
references.pmid: 14988124
references.citation: Nat Rev Clin Oncol. 2012 Jul 10;9(8):479-86
references.pmid: 22777058
references.citation: Mod Pathol. 2011 Jan;24(1):26-38
references.pmid: 20802467
references.citation: Nature. 2012 Apr 18;486(7403):346-52
references.pmid: 22522925
references.citation: J Clin Oncol. 2008 Sep 20;26(27):4442-8
references.pmid: 18802157